sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Report on Spire Healthcare Group plc Stake
The Vanguard Group, Inc. has disclosed its position in Spire Healthcare Group plc through a Form 8.3 filing, as required by Rule 8.3 of the Takeover Code. The disclosure, dated October 16, 2026, details Vanguard's interest in Spire Healthcare's securities, significant as it represents holdings of 1% or more. As of October 15, 2026, Vanguard controls 3.59% of Spire's ordinary shares, totaling 14,439,832 shares.
The filing also notes that Vanguard engaged in a sale of 1,096 ordinary shares at 2.48 GBP per unit. No agreements or derivatives are influencing Vanguard's voting rights or the future acquisition of related securities. No additional forms, such as a Supplemental Form 8, were included in the disclosure.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.